<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813421</url>
  </required_header>
  <id_info>
    <org_study_id>CHLA-15-00535</org_study_id>
    <nct_id>NCT02813421</nct_id>
  </id_info>
  <brief_title>Continue Glucose Monitoring Before Insulin Pump</brief_title>
  <official_title>Professional Continuous Glucose Monitoring Before Starting Insulin Pump Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to learn more about blood glucose control when people with Type 1&#xD;
      Diabetes switch to an insulin pump. The investigators hope to learn whether using a&#xD;
      continuous glucose monitor (CGM) helps to create personalized insulin doses that may lead to&#xD;
      stable blood glucoses and less frequent insulin pump dose changes during the transition to an&#xD;
      insulin pump.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized controlled study. Participants will be asked to wear a&#xD;
      Medtronic iPro2 continuous glucose monitor (CGM) 1-2 weeks prior to starting on insulin pump&#xD;
      therapy. Depending on randomization groups, participants will either have CGM data used&#xD;
      inform starting insulin pump doses (treatment group), or to standard of care for starting on&#xD;
      insulin pump (control group). Participants will wear the CGM again during the first 5 days of&#xD;
      pump start and at approximately 6 weeks after pump start, in order to collect blood glucose&#xD;
      data. Each time the CGM is worn, blood glucoses must be checked 6-8 times daily, and a&#xD;
      written log must be completed. Baseline medical information also will be collected at the&#xD;
      start of participation. Participants will also be asked to complete a questionnaire at&#xD;
      approximately 6 weeks after pump start. Participation in the study will be complete after a&#xD;
      standard of care follow up visit approximately 3 months after pump start.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">May 1, 2017</completion_date>
  <primary_completion_date type="Actual">May 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Time Within Target Blood Glucose (Range: 70-180 mg/dL)</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Time Within Target Blood Glucose (Range: 70-180 mg/dL)</measure>
    <time_frame>First 5 days of insulin pump therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Blood Glucose (mg/dL)</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
    <description>Other measures of glycemic variability obtained by iPro2 download</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage Time Hyperglycemic</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
    <description>Data obtained by iPro2 download</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Daily Insulin Dose (Units)</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
    <description>Will be obtained by insulin pump download.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage Basal Insulin (%)</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
    <description>Will be obtained by insulin pump download.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Number of Insulin Dose Adjustments</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
    <description>This data will be collected on standardized log sheets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Number of Phone Calls to Clinic Hotline</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
    <description>This data will be collected on standardized log sheets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Insulin Dose Adjustments Made Per Phone Call</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
    <description>This data will be collected on standardized log sheets.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episodes of DKA</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Number of Episodes of Severe Hypoglycemia</measure>
    <time_frame>First 6 weeks of insulin pump therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c (%)</measure>
    <time_frame>Baseline to 3 months post-pump start</time_frame>
    <description>Difference in HbA1c from baseline to 3 months post-pump start</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Satisfaction of Transition to Pump Therapy</measure>
    <time_frame>At 6 weeks after start of insulin pump therapy</time_frame>
    <description>6 question survey addressing patient/parent impressions of the process of transitioning to insulin pump therapy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>CGM Informed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CGM data was available for use when determining starting insulin pump doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CGM Informed</intervention_name>
    <arm_group_label>CGM Informed</arm_group_label>
    <other_name>iPro2 Professional Continuous Glucose Monitor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males and Females aged 2-24 years&#xD;
&#xD;
          2. Clinical diagnosis of Type 1 diabetes mellitus&#xD;
&#xD;
          3. Duration of diabetes: At least 6 months&#xD;
&#xD;
             - This will ensure some glycemic stability prior to study, and most children do not&#xD;
             start on an insulin pump until about 6 months into their diagnosis.&#xD;
&#xD;
          4. Basal/bolus insulin regimen using long-acting and rapid-acting insulin&#xD;
&#xD;
             - This will provide a uniform method of insulin therapy.&#xD;
&#xD;
          5. Willingness to perform at least 6-8 capillary blood glucose tests per day while&#xD;
             wearing the iPro速2&#xD;
&#xD;
          6. Willingness to wear the iPro速2 for 5 days continuously per insertion&#xD;
&#xD;
          7. Participant agrees to comply with the study protocol requirements&#xD;
&#xD;
          8. Informed Consent, Assent, HIPAA Authorization, and California Experimental Subject&#xD;
             Bill of Rights signed by the participant and/or parent guardian&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Comorbid conditions, including but not limited to cystic fibrosis, oncologic&#xD;
             processes, other systemic diseases that may affect overall glycemic control&#xD;
&#xD;
          2. Glucocorticoid use within 2 weeks of study enrollment&#xD;
&#xD;
          3. Concurrent use of other medications that may affect glycemic control&#xD;
&#xD;
          4. Prior CGM use in the past 6 months&#xD;
&#xD;
          5. The participant has any skin abnormality (e.g. psoriasis, rash, staphylococcus&#xD;
             infection) in the area of iPro速2 placement that has not been resolved at the time of&#xD;
             enrollment and would inhibit the participant from wearing the iPro速2.&#xD;
&#xD;
          6. Non-English or non-Spanish speaking&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jessica A Ferris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 2, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <results_first_submitted>January 25, 2019</results_first_submitted>
  <results_first_submitted_qc>May 3, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 25, 2021</results_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital Los Angeles</investigator_affiliation>
    <investigator_full_name>Jessica Ferris, MD</investigator_full_name>
    <investigator_title>Clinical Fellow</investigator_title>
  </responsible_party>
  <keyword>CGM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 8, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/21/NCT02813421/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>CGM Informed</title>
          <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CGM Informed</title>
          <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="11"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.4" spread="4.4"/>
                    <measurement group_id="B2" value="10.0" spread="3.0"/>
                    <measurement group_id="B3" value="10.6" spread="3.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <description>BMI Z-score refers to standard deviation above the mean. Mean= 50%ile = z-score of 0, Negative value is SD below the mean, Positive value is SD above the mean.</description>
          <units>z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.36" spread="0.58"/>
                    <measurement group_id="B2" value="1.38" spread="0.6"/>
                    <measurement group_id="B3" value="1.37" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tanner Stage</title>
          <description>Tanner stage represents pubertal stage. Tanner stage is a standardized measure to grade puberty on physical exam using a whole unit scale of 1 (pre-pubertal) through 5 (full pubertal). Insulin requires can differ depending on pubertal stage.</description>
          <units>Tanner Stage (1-5)</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="B2" value="2" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="B3" value="3" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hemoglobin A1c (%)</title>
          <units>Percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.6" spread="1.7"/>
                    <measurement group_id="B2" value="7.5" spread="0.94"/>
                    <measurement group_id="B3" value="7.55" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mean glucose (mg/dL)</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="173" spread="46"/>
                    <measurement group_id="B2" value="171" spread="38"/>
                    <measurement group_id="B3" value="172" spread="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Frequency of Blood Glucose Monitoring (times/day)</title>
          <units>Times/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.7" spread="2.6"/>
                    <measurement group_id="B2" value="6.7" spread="1.3"/>
                    <measurement group_id="B3" value="6.26" spread="1.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age of Diagnosis (years)</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8" spread="4.2"/>
                    <measurement group_id="B2" value="8.1" spread="3.3"/>
                    <measurement group_id="B3" value="8.09" spread="3.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of Diabetes (years)</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.3" spread="4.9"/>
                    <measurement group_id="B2" value="1.8" spread="1.0"/>
                    <measurement group_id="B3" value="2.50" spread="3.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Daily Insulin dose (u/kg/day)</title>
          <units>units/kg/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.96" spread="0.55"/>
                    <measurement group_id="B2" value="0.72" spread="0.28"/>
                    <measurement group_id="B3" value="0.80" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Daily Basal Insulin (%=percentage of total daily insulin dose that is used for basal insulin))</title>
          <description>Percentage of total daily insulin dose that is used for basal insulin</description>
          <units>Percentage of total daily insulin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.6" spread="10.2"/>
                    <measurement group_id="B2" value="40.2" spread="10.2"/>
                    <measurement group_id="B3" value="37.8" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Episodes of DKA</title>
          <units>Episodes</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Population total number of episodes of significant hypoglycemia</title>
          <units>Number of Episodes</units>
          <param>Number</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5"/>
                    <count group_id="B2" value="6"/>
                    <count group_id="B3" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage Time Within Target Blood Glucose (Range: 70-180 mg/dL)</title>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Time Within Target Blood Glucose (Range: 70-180 mg/dL)</title>
          <units>Percentage of time</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.7" spread="13"/>
                    <measurement group_id="O2" value="68.0" spread="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Time Within Target Blood Glucose (Range: 70-180 mg/dL)</title>
        <time_frame>First 5 days of insulin pump therapy</time_frame>
        <population>One control participant was lost to follow up after first 5 days of insulin pump therapy, therefore n=4 for this outcome, and not after.</population>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Time Within Target Blood Glucose (Range: 70-180 mg/dL)</title>
          <population>One control participant was lost to follow up after first 5 days of insulin pump therapy, therefore n=4 for this outcome, and not after.</population>
          <units>Percentage of time</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" spread="8.2"/>
                    <measurement group_id="O2" value="57.5" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Blood Glucose (mg/dL)</title>
        <description>Other measures of glycemic variability obtained by iPro2 download</description>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Blood Glucose (mg/dL)</title>
          <description>Other measures of glycemic variability obtained by iPro2 download</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137" spread="6.6"/>
                    <measurement group_id="O2" value="193" spread="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage Time Hyperglycemic</title>
        <description>Data obtained by iPro2 download</description>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Time Hyperglycemic</title>
          <description>Data obtained by iPro2 download</description>
          <units>Percentage of time</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7" spread="9.7"/>
                    <measurement group_id="O2" value="31.7" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Daily Insulin Dose (Units)</title>
        <description>Will be obtained by insulin pump download.</description>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Daily Insulin Dose (Units)</title>
          <description>Will be obtained by insulin pump download.</description>
          <units>Units/kg/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.67"/>
                    <measurement group_id="O2" value="0.87" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage Basal Insulin (%)</title>
        <description>Will be obtained by insulin pump download.</description>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Basal Insulin (%)</title>
          <description>Will be obtained by insulin pump download.</description>
          <units>Percentage of time</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5" spread="17"/>
                    <measurement group_id="O2" value="27.5" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Number of Insulin Dose Adjustments</title>
        <description>This data will be collected on standardized log sheets.</description>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Insulin Dose Adjustments</title>
          <description>This data will be collected on standardized log sheets.</description>
          <units>Adjustments</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.7" spread="4.0"/>
                    <measurement group_id="O2" value="12.7" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Number of Phone Calls to Clinic Hotline</title>
        <description>This data will be collected on standardized log sheets.</description>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Phone Calls to Clinic Hotline</title>
          <description>This data will be collected on standardized log sheets.</description>
          <units>Phone calls</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.33" spread="3.51"/>
                    <measurement group_id="O2" value="5.67" spread="2.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Insulin Dose Adjustments Made Per Phone Call</title>
        <description>This data will be collected on standardized log sheets.</description>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Insulin Dose Adjustments Made Per Phone Call</title>
          <description>This data will be collected on standardized log sheets.</description>
          <units>Changes/call</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.39" spread="0.55"/>
                    <measurement group_id="O2" value="1.96" spread="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Episodes of DKA</title>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Episodes of DKA</title>
          <units>Episodes</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Number of Episodes of Severe Hypoglycemia</title>
        <time_frame>First 6 weeks of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Episodes of Severe Hypoglycemia</title>
          <units>Number of Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemoglobin A1c (%)</title>
        <description>Difference in HbA1c from baseline to 3 months post-pump start</description>
        <time_frame>Baseline to 3 months post-pump start</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobin A1c (%)</title>
          <description>Difference in HbA1c from baseline to 3 months post-pump start</description>
          <units>Percentage of HbA1c</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.27" spread="0.5"/>
                    <measurement group_id="O2" value="0.025" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Satisfaction of Transition to Pump Therapy</title>
        <description>6 question survey addressing patient/parent impressions of the process of transitioning to insulin pump therapy.</description>
        <time_frame>At 6 weeks after start of insulin pump therapy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CGM Informed</title>
            <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Satisfaction of Transition to Pump Therapy</title>
          <description>6 question survey addressing patient/parent impressions of the process of transitioning to insulin pump therapy.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>CGM Informed</title>
          <description>CGM data was available for use when determining starting insulin pump doses.&#xD;
CGM Informed</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>CGM data will remain secure and not used. Starting insulin pump doses will be made by standard of care.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jessica Ferris</name_or_title>
      <organization>Children's Hospital Los Angeles</organization>
      <phone>323-361-4606</phone>
      <email>jeferris@chla.usc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

